MEGAN GOSSACK: Open Payments
NPI 1750132353 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,128 in 59 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $326 · 2025 $1,128
Food & beverage: $1,128
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $202 |
| AstraZeneca Pharmaceuticals LP | 10 | $160 |
| Sumitomo Pharma America, Inc. | 4 | $91 |
| Amgen Inc. | 5 | $88 |
| Radius Health, Inc. | 3 | $65 |
| Novo Nordisk Inc | 3 | $63 |
| Lilly USA, LLC | 4 | $62 |
| PFIZER INC. | 2 | $45 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $44 |
| Grifols USA, LLC | 2 | $44 |
Products named: UBRELVY, AIRSUPRA, GEMTESA, EVENITY, VRAYLAR, Tymlos, MOUNJARO, XIFAXAN.
Industry payments across CO — which companies pay providers there.
